| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |